Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus

Hepatology

Volumn 62, Issue 2, 2015, Pages 375-386

  Chen, Huey Ling ^a   Lee, Chien Nan ^a   Chang, Chin Hao ^a   Ni, Yen Hsuan ^a   Shyu, Ming Kwang ^a   Chen, Shih Ming ^c   Hu, Jen Jan ^c   Lin, Hans Hsienhong ^d   Zhao, Lu Lu ^d   Mu, Shu Chi ^e   Lai, Ming Wei ^f   Lee, Chyi Long ^f   Lin, Hsien Ming ^g   Tsai, Ming Song ^h   Hsu, Jenn Jeih ^f   Chen, Ding Shinn ^a,b,i   Chan, K Arnold ^a   Chang, Mei Hwei ^a   Su, Yi Ning ^b   Shih, Jin Chung ^b   Chao, Kuang Han ^b   Wu, Jia Feng ^b   Hsu, Hong Yuan ^b   Liu, Chun Jen ^b   Su, Tung Hung ^b   Lin, Chin Chuan ^c   Lin, Pei Yin ^c   Yang, Wen Rong ^c   Yang, Chun Kuang ^j   Chang, Yin Kuang ^j   Chen, Kuo Hu ^j   Lin, Yu Hung ^g   Chen, Heng Ju ^g   Pan, Hun Shan ^g   Lau, Beng Huat ^e   Cheng, Po Jen ^f   Chang, Yao Lung ^f   Chiueh, Ho Yen ^f   Wang, Tzu Hao ^f   Lo, Liang Ming ^g   Hsieh, Chia Lin ^g   Cheng, Shao Wen ^f   Lin, Lung Huang ^h   She, Bo Qing ^g   Koh, King Jun ^e   Hung, Yi Li ^e   Peng, Fu Shiang ^g   Lin, Yu Cheng ^g   Wu, Tzee Chung ^e   Chen, Chih Yao ^k   Chen, Chie Pein ^g   Huang, Jian Pei ^g   Yeung, Chun Yan ^l   Lin, Chen Ju ^l   Chiu, Wei Tsung ^g   Wang, Duo Sheng ^g   Lin, Wen Terng ^m   Hwang, Kwei Shuai ⁿ   Huang, Ching Feng ⁿ   more..

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c TAIWAN ADVENTIST HOSPITAL   (Taiwan)

^d BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^e SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^f CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^g FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^h CATHAY GENERAL HOSPITAL   (Taiwan)

ⁱ GENOMICS RESEARCH CENTER   (Taiwan)

^j Taipei Tzu Chi Hospital   (Taiwan)

^k TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^l MACKAY MEMORIAL HOSPITAL   (Taiwan)

^m EN CHU KONG HOSPITAL   (Taiwan)

ⁿ TRI SERVICE GENERAL HOSPITAL   (Taiwan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CREATINE KINASE; CREATININE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; TENOFOVIR DISOPROXIL; VIRUS DNA; ADENINE; PHOSPHONIC ACID DERIVATIVE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMNIOCENTESIS; ANTIVIRAL THERAPY; AREA UNDER THE CURVE; ARTICLE; CONGENITAL MALFORMATION; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; FEMALE; GESTATIONAL AGE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMORAL IMMUNITY; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PREGNANT WOMAN; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUERPERIUM; VIRUS TRANSMISSION; ANALOGS AND DERIVATIVES; CONTROLLED CLINICAL TRIAL; DRUG EFFECTS; FOLLOW UP; HEPATITIS B, CHRONIC; MATERNAL AGE; NEWBORN; PATIENT SELECTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PREVENTION AND CONTROL; REFERENCE VALUE; RISK ASSESSMENT; TAIWAN; TRANSMISSION; TREATMENT OUTCOME; VERTICAL TRANSMISSION; VIRUS LOAD; YOUNG ADULT;

ADENINE; ADULT; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; MATERNAL AGE; MULTIVARIATE ANALYSIS; ORGANOPHOSPHONATES; PATIENT SELECTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; TAIWAN; TREATMENT OUTCOME; VIRAL LOAD; YOUNG ADULT;

EID: 84938213859     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27837     Document Type: Article

References (34)

1. Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975;292:771-774.
2. Beasley RP, Hwang LY, Stevens CE, Lin CC, Hsieh FJ, Wang KY, et al. Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: final report of a randomized double-blind, placebo-controlled trial. Hepatology 1983;3:135-141.
3. Fortuin M, Chotard J, Jack AD, Maine NP, Mendy M, Hall AJ, et al. Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation. Lancet 1993;341:1129-1131.
4. Ni YH, Huang LM, Chang MH, Yen CJ, Lu CY, You SL, et al. Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies. Gastroenterology 2007;132:1287-1293.
5. Kubo A, Shlager L, Marks AR, Lakritz D, Beaumont C, Gabellini K, et al. Prevention of vertical transmission of hepatitis B: an observational study. Ann Intern Med 2014;160:828-835.
6. Chen HL, Lin LH, Hu FC, Lee JT, Lin WT, Yang YJ, et al. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology 2012;142:773-781.
7. Song YM, Sung J, Yang S, Choe YH, Chang YS, Park WS. Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus. Eur J Pediatr 2007;166:813-818.
8. Wiseman E, Fraser MA, Holden S, Glass A, Kidson BL, Heron LG, et al. Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust 2009;190:489-492.
9. Wen WH, Chang MH, Zhao LL, Ni YH, Hsu HY, Wu JF, et al. Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention. J Hepatol 2013;59:24-30.
10. Chang MH, Chen TH, Hsu HM, Wu TC, Kong MS, Liang DC, et al. Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems. Clin Cancer Res 2005;11:7953-7957.
11. Chang MH, You SL, Chen CJ, Liu CJ, Lee CM, Lin SM, et al. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst 2009;101:1348-1355.
12. Jonas MM. Hepatitis B and pregnancy: an underestimated issue. Liver Int 2009;29(Suppl. 1):133-139.
13. Patton H, Tran TT. Management of hepatitis B during pregnancy. Nat Rev Gastroenterol Hepatol 2014;11:402-409.
14. Pan CQ, Lee HM. Antiviral therapy for chronic hepatitis B in pregnancy. Semin Liver Dis 2013;33:138-146.
15. Chang MH. Paediatrics: children need optimal management of chronic hepatitis B. Nat Rev Gastroenterol Hepatol 2013;10:505-506.
16. Chen CY, Chang MH. Hepatitis B and pregnancy, the scientific basis for perinatal prevention. Fetal Matern Med Rev 2010;21:89-113.
17. Antiretroviral Pregnancy Registry Steering Committee. Antiretroviral Pregnancy Registry International Interim Report for January 1, 1989, through July 31, 2014. Wilmington, NC: Registry Coordinating Center; 2014. http://www.apregistry.com/InterimReport.aspx. Accessed April 24, 2015.
18. van Zonneveld M, van Nunen AB, Niesters HG, de Man RA, Schalm SW, Janssen HL. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat 2003;10:294-297.
19. Xu WM, Cui YT, Wang L, Yang H, Liang ZQ, Li XM, et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat 2009;16:94-103.
20. Han GR, Cao MK, Zhao W, Jiang HX, Wang CM, Bai SF, et al. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J Hepatol 2011;55:1215-1221.
21. Greenup AJ, Tan PK, Nguyen V, Glass A, Davison S, Chatterjee U, et al. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus. J Hepatol 2014;61:502-507.
22. Heathcote EJ, Marcellin P, Buti M, Gane E, De Man RA, Krastev Z, et al. Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B. Gastroenterology 2011;140:132-143.
23. Chan HL, Chan CK, Hui AJ, Chan S, Poordad F, Chang TT, et al. Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNA. Gastroenterology 2014;146:1240-1248.
24. Tang JR, Hsu HY, Lin HH, Ni YH, Chang MH. Hepatitis B surface antigenemia at birth: a long-term follow-up study. J Pediatr 1998;133:374-377.
25. Lin HH, Lee TY, Chen DS, Sung JL, Ohto H, Etoh T, et al. Transplacental leakage of HBeAg-positive maternal blood as the most likely route in causing intrauterine infection with hepatitis B virus. J Pediatr 1987;111:877-881.
26. Pan CQ, Zou HB, Chen Y, Zhang X, Zhang H, Li J, et al. Cesarean section reduces perinatal transmission of hepatitis B virus infection from hepatitis B surface antigen-positive women to their infants. Clin Gastroenterol Hepatol 2013;11:1349-1355.
27. Yi W, Pan CQ, Hao J, Hu Y, Liu M, Li L, et al. Risk of vertical transmission of hepatitis B after amniocentesis in HBs antigen-positive mothers. J Hepatol 2014;60:523-529.
28. World Health Organization. Hepatitis B. Fact Sheet 204. http://www.who.int/mediacentre/factsheets/fs204/en/. Accessed 2014.
29. Yoon JH, Shin S, In J, Chang JY, Song EY, Roh EY. Association of HLA alleles with the responsiveness to hepatitis B virus vaccination in Korean infants. Vaccine 2014;32:5638-5644.
30. Yu MM, Jiang Q, Ji Y, Wu KH, Ju LL, Tang X, et al. Comparison of telbivudine versus lamivudine in interrupting perinatal transmission of hepatitis B virus. J Clin Virol 2014;61:55-60.
31. Zhang H, Pan CQ, Pang Q, Tian R, Yan M, Liu X. Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice. Hepatology 2014;60:468-476.
32. Celen MK, Mert D, Ay M, Dal T, Kaya S, Yildirim N, et al. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection. World J Gastroenterol 2013;19:9377-9382.
33. Pan CQ, Mi LJ, Bunchorntavakul C, Karsdon J, Huang WM, Singhvi G, et al. Tenofovir disoproxil fumarate for prevention of vertical transmission of hepatitis B virus infection by highly viremic pregnant women: a case series. Dig Dis Sci 2012;57:2423-2429.
34. Nguyen V, Tan PK, Greenup AJ, Glass A, Davison S, Samarasinghe D, et al. Anti-viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post-partum flare. Aliment Pharmacol Ther 2014;39:1225-1234.